ID   P2RX1_RAT               Reviewed;         399 AA.
AC   P47824;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   02-OCT-2024, entry version 176.
DE   RecName: Full=P2X purinoceptor 1;
DE            Short=P2X1;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
DE   AltName: Full=RP-2 protein;
GN   Name=P2rx1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORTER ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Vas deferens;
RX   PubMed=7523951; DOI=10.1038/371516a0;
RA   Valera S., Hussy N., Evans R.J., Adami N., North R.A., Surprenant A.,
RA   Buell G.N.;
RT   "A new class of ligand-gated ion channel defined by P2x receptor for
RT   extracellular ATP.";
RL   Nature 371:516-519(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 189-399, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley; TISSUE=Thymus;
RX   PubMed=2072913; DOI=10.1128/mcb.11.8.4177-4188.1991;
RA   Owens G.P., Hahn W.E., Cohen J.J.;
RT   "Identification of mRNAs associated with programmed cell death in immature
RT   thymocytes.";
RL   Mol. Cell. Biol. 11:4177-4188(1991).
RN   [4]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=9606184; DOI=10.1093/emboj/17.11.3016;
RA   Nicke A., Baeumert H.G., Rettinger J., Eichele A., Lambrecht G.,
RA   Mutschler E., Schmalzing G.;
RT   "P2X1 and P2X3 receptors form stable trimers: a novel structural motif of
RT   ligand-gated ion channels.";
RL   EMBO J. 17:3016-3028(1998).
RN   [5]
RP   SUBUNIT.
RX   PubMed=9855626; DOI=10.1124/mol.54.6.989;
RA   Torres G.E., Haines W.R., Egan T.M., Voigt M.M.;
RT   "Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated
RT   ion channel.";
RL   Mol. Pharmacol. 54:989-993(1998).
RN   [6]
RP   SUBUNIT.
RX   PubMed=15313628; DOI=10.1016/j.jmb.2004.06.092;
RA   Aschrafi A., Sadtler S., Niculescu C., Rettinger J., Schmalzing G.;
RT   "Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor
RT   subtypes.";
RL   J. Mol. Biol. 342:333-343(2004).
RN   [7]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=15686495; DOI=10.1111/j.1471-4159.2004.02939.x;
RA   Nicke A., Kerschensteiner D., Soto F.;
RT   "Biochemical and functional evidence for heteromeric assembly of P2X1 and
RT   P2X4 subunits.";
RL   J. Neurochem. 92:925-933(2005).
CC   -!- FUNCTION: ATP-gated nonselective transmembrane cation channel permeable
CC       to potassium, sodium and with relatively high calcium permeability
CC       (PubMed:15686495, PubMed:7523951, PubMed:9606184). Furthermore, CTP
CC       functions as a weak affinity agonist for P2RX1 (By similarity). Plays a
CC       role a role in urogenital, immune and cardiovascular function (By
CC       similarity). Specifically, plays an important role in neurogenic
CC       contraction of smooth muscle of the vas deferens, and therefore is
CC       essential for normal male reproductive function (By similarity). In
CC       addition, contributes to smooth muscle contractions of the urinary
CC       bladder (By similarity). On platelets, contributes to platelet
CC       activation and aggregation and thereby, also to thrombosis (By
CC       similarity). On neutrophils, it is involved in chemotaxis and in
CC       mitigating the activation of circulating cells (By similarity).
CC       {ECO:0000250|UniProtKB:P51575, ECO:0000250|UniProtKB:P51576,
CC       ECO:0000269|PubMed:15686495, ECO:0000269|PubMed:7523951,
CC       ECO:0000269|PubMed:9606184}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:7523951};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000250|UniProtKB:P51575};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000250|UniProtKB:P51575};
CC   -!- ACTIVITY REGULATION: Activated by low concentrations of ATP (<1 uM)
CC       (PubMed:7523951). Undergoes rapid desensitisation. Sensitives to the
CC       ATP agonist:alpha/beta-methylene-ATP. Modulated by cholesterol (By
CC       similarity). {ECO:0000250|UniProtKB:P51575,
CC       ECO:0000269|PubMed:7523951}.
CC   -!- SUBUNIT: Functional P2XRs are organized as homomeric and heteromeric
CC       trimers. Homotrimer (PubMed:9606184). Forms heterodimer with P2RX2
CC       (PubMed:15313628). Forms heterodimer with P2RX4 (PubMed:15686495).
CC       Forms heterodimer with P2RX5 (PubMed:9855626).
CC       {ECO:0000269|PubMed:15313628, ECO:0000269|PubMed:15686495,
CC       ECO:0000269|PubMed:9606184, ECO:0000269|PubMed:9855626}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9606184};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P56373}.
CC       Note=Detected at plasma membrane lipid rafts.
CC       {ECO:0000250|UniProtKB:P51575}.
CC   -!- TISSUE SPECIFICITY: High levels in vas deferens and urinary bladder.
CC       Lower extent in spinal cord, coeliac ganglion, lung and spleen
CC       (probably in the smooth muscle part of both organs).
CC       {ECO:0000269|PubMed:7523951}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during apoptosis in thymocytes.
CC       {ECO:0000269|PubMed:2072913}.
CC   -!- INDUCTION: By irradiation and dexamethasone (in thymocytes).
CC   -!- DOMAIN: The N-terminal 20 to 23 and 27 to 29 residues seem to play a
CC       role in the cholesterol-dependent gating of this receptor.
CC       {ECO:0000250|UniProtKB:P51575}.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X80477; CAA56647.1; -; mRNA.
DR   EMBL; BC061742; AAH61742.1; -; mRNA.
DR   EMBL; M80602; AAA42065.1; -; mRNA.
DR   PIR; S50860; S50860.
DR   RefSeq; NP_001135839.1; NM_001142367.2.
DR   RefSeq; NP_001272344.1; NM_001285415.1.
DR   RefSeq; NP_037129.1; NM_012997.3.
DR   AlphaFoldDB; P47824; -.
DR   SMR; P47824; -.
DR   STRING; 10116.ENSRNOP00000024068; -.
DR   BindingDB; P47824; -.
DR   ChEMBL; CHEMBL2530; -.
DR   DrugCentral; P47824; -.
DR   GuidetoPHARMACOLOGY; 478; -.
DR   TCDB; 1.A.7.1.1; the atp-gated p2x receptor cation channel (p2x receptor) family.
DR   GlyCosmos; P47824; 4 sites, No reported glycans.
DR   GlyGen; P47824; 4 sites.
DR   iPTMnet; P47824; -.
DR   PhosphoSitePlus; P47824; -.
DR   PaxDb; 10116-ENSRNOP00000024068; -.
DR   DNASU; 25505; -.
DR   Ensembl; ENSRNOT00000024068.7; ENSRNOP00000024068.4; ENSRNOG00000017606.7.
DR   Ensembl; ENSRNOT00055047515; ENSRNOP00055039092; ENSRNOG00055027418.
DR   Ensembl; ENSRNOT00060031979; ENSRNOP00060026000; ENSRNOG00060018550.
DR   Ensembl; ENSRNOT00065043106; ENSRNOP00065035303; ENSRNOG00065025037.
DR   GeneID; 25505; -.
DR   KEGG; rno:25505; -.
DR   AGR; RGD:3240; -.
DR   CTD; 5023; -.
DR   RGD; 3240; P2rx1.
DR   eggNOG; ENOG502QSUI; Eukaryota.
DR   GeneTree; ENSGT01020000230351; -.
DR   HOGENOM; CLU_034469_2_0_1; -.
DR   InParanoid; P47824; -.
DR   OMA; DCDLDWH; -.
DR   OrthoDB; 5312692at2759; -.
DR   PhylomeDB; P47824; -.
DR   Reactome; R-RNO-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-RNO-418346; Platelet homeostasis.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:P47824; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000017606; Expressed in pancreas and 16 other cell types or tissues.
DR   ExpressionAtlas; P47824; baseline and differential.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0004931; F:extracellularly ATP-gated monoatomic cation channel activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0099604; F:ligand-gated calcium channel activity; ISO:RGD.
DR   GO; GO:0005261; F:monoatomic cation channel activity; ISO:RGD.
DR   GO; GO:0000166; F:nucleotide binding; IDA:RGD.
DR   GO; GO:0097159; F:organic cyclic compound binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; ISO:RGD.
DR   GO; GO:0043924; F:suramin binding; IDA:RGD.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0046513; P:ceramide biosynthetic process; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0007320; P:insemination; ISO:RGD.
DR   GO; GO:0098655; P:monoatomic cation transmembrane transport; IDA:RGD.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; IMP:RGD.
DR   GO; GO:0006811; P:monoatomic ion transport; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; IDA:RGD.
DR   GO; GO:0030168; P:platelet activation; ISO:RGD.
DR   GO; GO:1905665; P:positive regulation of calcium ion import across plasma membrane; IDA:RGD.
DR   GO; GO:0043270; P:positive regulation of monoatomic ion transport; ISO:RGD.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; ISO:RGD.
DR   GO; GO:0099509; P:regulation of presynaptic cytosolic calcium ion concentration; IDA:SynGO.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; ISO:RGD.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IDA:SynGO.
DR   GO; GO:0003056; P:regulation of vascular associated smooth muscle contraction; ISO:RGD.
DR   GO; GO:0019229; P:regulation of vasoconstriction; ISO:RGD.
DR   GO; GO:0033198; P:response to ATP; ISO:RGD.
DR   GO; GO:0002554; P:serotonin secretion by platelet; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IMP:RGD.
DR   Gene3D; 1.10.287.940; atp-gated p2x4 ion channel; 1.
DR   Gene3D; 2.60.490.10; atp-gated p2x4 ion channel domain; 1.
DR   InterPro; IPR003044; P2X1_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   InterPro; IPR053792; P2X_RECEPTOR_CS.
DR   NCBIfam; TIGR00863; P2X; 1.
DR   PANTHER; PTHR10125; P2X PURINOCEPTOR; 1.
DR   PANTHER; PTHR10125:SF9; P2X PURINOCEPTOR 1; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01308; P2X1RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; ATP-binding; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..399
FT                   /note="P2X purinoceptor 1"
FT                   /id="PRO_0000161547"
FT   TOPO_DOM        1..28
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   TRANSMEM        29..50
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        51..338
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   TRANSMEM        339..358
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        359..399
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   REGION          331..338
FT                   /note="Pore-forming motif"
FT                   /evidence="ECO:0000255"
FT   REGION          374..399
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         68
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         70
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         70
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         140
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         186
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         186
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         286
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         290
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         290
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         292
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         292
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         309
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         309
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   MOD_RES         387
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51575"
FT   MOD_RES         388
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51575"
FT   MOD_RES         389
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P51575"
FT   CARBOHYD        153
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        210
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        300
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        117..165
FT                   /evidence="ECO:0000250|UniProtKB:P51575"
FT   DISULFID        126..149
FT                   /evidence="ECO:0000250|UniProtKB:P51575"
FT   DISULFID        132..159
FT                   /evidence="ECO:0000250|UniProtKB:P51575"
FT   DISULFID        217..227
FT                   /evidence="ECO:0000250|UniProtKB:P51575"
FT   DISULFID        261..270
FT                   /evidence="ECO:0000250|UniProtKB:P51575"
FT   CONFLICT        189..201
FT                   /note="IKNSISFPRFKVN -> PQLAHGCYPCPPH (in Ref. 3;
FT                   AAA42065)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   399 AA;  44957 MW;  04B79E171D78AEC2 CRC64;
     MARRLQDELS AFFFEYDTPR MVLVRNKKVG VIFRLIQLVV LVYVIGWVFV YEKGYQTSSD
     LISSVSVKLK GLAVTQLQGL GPQVWDVADY VFPAHGDSSF VVMTNFIVTP QQTQGHCAEN
     PEGGICQDDS GCTPGKAERK AQGIRTGNCV PFNGTVKTCE IFGWCPVEVD DKIPSPALLR
     EAENFTLFIK NSISFPRFKV NRRNLVEEVN GTYMKKCLYH KIQHPLCPVF NLGYVVRESG
     QDFRSLAEKG GVVGITIDWK CDLDWHVRHC KPIYQFHGLY GEKNLSPGFN FRFARHFVQN
     GTNRRHLFKV FGIHFDILVD GKAGKFDIIP TMTTIGSGIG IFGVATVLCD LLLLHILPKR
     HYYKQKKFKY AEDMGPGEGE HDPVATSSTL GLQENMRTS
//
